Healthy Subjects Clinical Trial
Official title:
Effects of the Supplementation of Essence of Chicken on Physical Fatigue and Brain Functions Such as Working Memory and Attention Among Healthy Adults
Verified date | February 2017 |
Source | Sprim Advanced Life Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In Southeast Asia, Essence of Chicken, a chicken-meat-extract, is a popular beverage and is
consumed as a traditional remedy for several ailments, including the use as a nutritional
supplement for sickness, enhancement of mental efficiency, and recovery from mental fatigue.
While the elderly use it as a nutritional supplement, students use it for relief from
anxiety during exam times.
The present study is conducted in order to assess the effects of BEC on various physical and
mental parameters including physical fatigue, working memory and attention, mood and stress,
in comparison to placebo.
Status | Completed |
Enrollment | 364 |
Est. completion date | January 30, 2017 |
Est. primary completion date | November 7, 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Normal BMI - Not continuously taken Essence of Chicken for the last 3 months - Physical and psychological fatigue inclusion criteria/test/cutoff using CFQ (where individuals' CFQ scores 4 or above) Exclusion Criteria: - Suffering from chronic or malignant diseases e.g. cancer, heart, liver, renal or other metabolic diseases. - Any psychiatric or neurological disease - Pregnant and lactating women - Subjects participated in any investigational drug trial within 4 weeks before screening - Consumption of food supplement in the previous 2 weeks - Professional athletes - Subjects with recent lifestyle changes in the past 4 weeks - History of allergy to chicken meat and seafood |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Sprim Advanced Life Sciences | Cerebos |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fatigue-vitality | Psychometric tests SF-36 (score 100%) | 4 weeks | |
Primary | Physical fatigue | Chalder Fatigue Questionnaire (score 0-33) | 4 weeks | |
Primary | Attention | Stroop (mean latency and proportion correct) | 4 weeks | |
Primary | Sustained attention | Sustained Attention to Response Task (mean latency and % of correct trials) | 4 weeks | |
Primary | Working memory | Digit Span test (Maximal FORWARD digit span and Maximal BACKWARD digit span, etc) | 4 weeks | |
Secondary | Mood | POMS brief is used as a psychometric test to measure mood (6 domains). | 4 weeks | |
Secondary | Stress | DASS is used as a psychometric test to measure stress (score 0-42). | 4 weeks | |
Secondary | Adverse effects | Comparison of adverse events on IP and placebo groups. | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05483998 -
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT02417714 -
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
|
||
Recruiting |
NCT02235012 -
Cognitive Biases Under Ketamine
|
N/A | |
Completed |
NCT05088343 -
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04418973 -
Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
|
N/A | |
Not yet recruiting |
NCT06248801 -
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
|
Phase 1 | |
Terminated |
NCT04068259 -
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03279302 -
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06233162 -
Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
|
Phase 1 | |
Recruiting |
NCT04159844 -
Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects
|
N/A | |
Completed |
NCT06137911 -
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
|
Phase 1 | |
Completed |
NCT04849286 -
Measurement of HTL0016878 in Cerebrospinal Fluid
|
Phase 1 | |
Not yet recruiting |
NCT06233227 -
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
|
Phase 1 | |
Completed |
NCT04096157 -
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
|
Phase 1 | |
Completed |
NCT01200368 -
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
|
Phase 3 | |
Recruiting |
NCT05805033 -
Peri-Implant Soft Tissue Integration in Humans: Influence of Material
|
N/A | |
Completed |
NCT04027803 -
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®
|
Phase 1 | |
Recruiting |
NCT03467880 -
Multicenter Study of Impulse Oscillometry in Chinese
|
N/A | |
Completed |
NCT02903095 -
Single Ascending Dose Study of TD-1439 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT02341508 -
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
|
Phase 1 |